Mitsubishi UFJ Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.5M | Buy |
|
|||||
|
2025
Q1 | $8.51M | Hold |
|
|||||
|
2024
Q4 | $10.6M | Buy |
|
|||||
|
2024
Q3 | $7.82M | Buy |
|
|||||
|
2024
Q2 | $8.87M | Buy |
|
|||||
|
2024
Q1 | $7.61M | Buy |
|
|||||
|
2023
Q4 | $5.47M | Buy |
|
|||||
|
2023
Q3 | $4.63M | Buy |
|
|||||
|
2023
Q2 | $3.87M | Buy |
|
|||||
|
2023
Q1 | $3.54M | Buy |
|
|||||
|
2022
Q4 | $3.68M | Buy |
|
|||||
|
2022
Q3 | $2.93M | Sell |
|
|||||
|
2022
Q2 | $2.69M | Buy |
|
|||||
|
2022
Q1 | $2.21M | Sell |
|
|||||
|
2021
Q4 | $2.11M | Buy |
|
|||||
|
2021
Q3 | $2.03M | Buy |
|
|||||
|
2021
Q2 | $2.03M | Buy |
|
|||||
|
2021
Q1 | $1.79M | Buy |
|
|||||
|
2020
Q4 | $1.64M | Buy |
|
|||||
|
2020
Q3 | $1.56M | Buy |
|
|||||
|
2020
Q2 | $1.72M | Buy |
|
|||||
|
2020
Q1 | $1.13M | Sell |
|
|||||
|
2019
Q4 | $1.57M | Buy |
|